PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,297,606 | +33.5% | 95,169 | +11.4% | 0.00% | 0.0% |
Q1 2024 | $2,470,622 | +26.2% | 85,400 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $1,958,222 | +34.5% | 85,400 | -2.1% | 0.00% | 0.0% |
Q3 2023 | $1,455,697 | -34.3% | 87,272 | +8.8% | 0.00% | 0.0% |
Q2 2023 | $2,215,124 | +77.7% | 80,200 | +48.0% | 0.00% | 0.0% |
Q1 2023 | $1,246,600 | +110.8% | 54,200 | 0.0% | 0.00% | – |
Q4 2022 | $591,322 | +75.5% | 54,200 | +35.5% | 0.00% | – |
Q3 2022 | $337,000 | -7.4% | 40,000 | -13.0% | 0.00% | – |
Q2 2022 | $364,000 | -87.8% | 46,000 | -63.6% | 0.00% | -100.0% |
Q1 2022 | $2,995,000 | +90.8% | 126,463 | +175.5% | 0.00% | 0.0% |
Q4 2021 | $1,570,000 | +93.1% | 45,900 | 0.0% | 0.00% | – |
Q3 2021 | $813,000 | -60.5% | 45,900 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $2,060,000 | +159.8% | 45,900 | +50.0% | 0.00% | – |
Q1 2021 | $793,000 | +40.6% | 30,600 | +9.3% | 0.00% | – |
Q4 2020 | $564,000 | +3.1% | 28,000 | 0.0% | 0.00% | – |
Q3 2020 | $547,000 | +10.7% | 28,000 | 0.0% | 0.00% | – |
Q2 2020 | $494,000 | +333.3% | 28,000 | +73.9% | 0.00% | – |
Q1 2020 | $114,000 | +28.1% | 16,100 | +27.8% | 0.00% | – |
Q4 2019 | $89,000 | -41.1% | 12,600 | 0.0% | 0.00% | – |
Q3 2019 | $151,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 2,449,183 | $43,253,000 | 8.50% |
BVF INC/IL | 2,367,288 | $41,806,000 | 2.58% |
RTW INVESTMENTS, LP | 3,383,208 | $59,747,000 | 1.68% |
Novo Holdings A/S | 824,169 | $14,555,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,013,495 | $17,898,000 | 0.52% |
Sofinnova Investments, Inc. | 326,064 | $5,758,000 | 0.36% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $44,150,000 | 0.35% |
Virtus ETF Advisers LLC | 21,639 | $382,000 | 0.18% |
Baker Brothers Advisors | 1,911,446 | $33,756,000 | 0.15% |
King Wealth Management Group | 22,000 | $389,000 | 0.11% |